New drug shows promise for Hard-to-Treat heart and lung condition
Disease control
Recruiting now
This study tests an experimental drug called TX000045 in people who have high blood pressure in the lungs caused by a specific type of heart failure (HFpEF). About 180 adults will receive either the drug or a placebo for 24 weeks to see if it improves blood flow and is safe. The …
Phase: PHASE2 • Sponsor: Tectonic Therapeutic • Aim: Disease control
Last updated May 17, 2026 01:18 UTC